The Effectiveness of Cognitive Behavioral Stress Management on  Health-Related Quality of Life, Diabetes Management Self-Efficacy, and  Treatment Adherence in Type 2 Diabetes

Samaneh  Motaghi; Isaac  Rahimian Boogar; Shahab  Moradi; Nemat  Setoodeh Asl

doi:10.18502/ijdo.v15i1.12207

Samaneh Motaghi Ph.D Student of Psychology, Semnan branch, Islamic Azad University, Semnan, Iran.
Isaac Rahimian Boogar Associate Professor, Department of Clinical Psychology, Faculty of Psychology and Educational Sciences, Semnan University, Semnan, Iran.
Shahab Moradi Assistant Professor, Department of Psychology, Semnan Branch, Islamic Azad University, Semnan, Iran.
Nemat Setoodeh Asl Associate Professor, Department of Psychology, Semnan Branch, Islamic Azad Univrsity, Semnan, Iran.

DOI: https://doi.org/10.18502/ijdo.v15i1.12207

Keywords: Cognitive-behavioral therapy, Stress reduction, Quality of life, Adherence to treatment, Self-efficacy, Diabetes

Abstract

Objective: This study aimed to investigate the effectiveness of cognitive behavioral stress management (CBSM) on health-related quality of life (HRQOL), self-efficacy of diabetes management, and adherence to treatment of patients with type 2 diabetes.

Materials and Methods: The present study was a semi-experimental study with a control group. The research samples included 30 patients with type 2 diabetes. Data collection tools in this study included the Boyer & Earp quality of life (QOL) scale for patients with diabetes (D-39), the diabetes management self-efficacy scale (DMSES), and treatment adherence questionnaire in patients with chronic diseases. The CBSM therapy was performed in 8 sessions for the experimental group. To analyze the data, a univariate analysis of covariance was used with SPSS-23 software.

Results: The results showed that the CBSM had a significant effect on the overall health-based QOL (F=8.620; P=0.007), diabetes management self-efficacy (F=12.021; P=0.002), and treatment adherence (F=83.253; P=0.0001). In addition, the CBSM has a significant effect on diabetes control (F=8.932; P=0.007), anxiety and worry (F=5.023; P=0.035), and sexual functioning (F=7.611; P=0.011), diet (F=10.041; P=0.004), therapeutic regimen (F=24.250; P=0.0001), making effort for treatment (F=22.987; P=0.0001), intention to take the treatment (F=108.001; P=0.0001), adaptability (F=28.704; P=0.0001), and integrating illness into life (F=38.263; P=0.0001).

Conclusion: The CBSM intervention can be used to improve health-based QOL, diabetes management self-efficacy, and treatment adherence in type 2 diabetes patients.